Omics and cachexia
Authors:
- Nicolas TardifNTNicolas Tardif
- Olav RooyackersOROlav Rooyackers
- 1 May 2017
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Clinical Nutrition and Metabolic Care
- Vol. 20 (3) , 181-185
Abstract
The purpose of this review is to recapture recent advances in cachexia-related diseases, mainly cancer cachexia, and treatment using genomic, transcriptomics, proteomic, and metabolomics-related techniques. From recent studies in the cancer cachexia field it is clear that the tumor has a direct effect on distant organs via its secretome. The affected pathways on the other hand were largely known from earlier studies with changes in energy-related pathways (mainly lipid metabolism) and the protein degradation pathways. Treatment-oriented studies use mostly rodent models and in-vivo cultures and it is too early for human studies. Omics tools are powerful if used in the right way. Omics research has identified the tumor as an important player in cancer cachexia and some interesting novel treatments have been found in experimental models.Keywords
This publication has 16 references indexed in Scilit:
- Omics/systems biology and cancer cachexiaSeminars in Cell & Developmental Biology, 2016
- Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexiaMolecular Metabolism, 2016
- Cardiac and skeletal muscles show molecularly distinct responses to cancer cachexiaPhysiological Genomics, 2015
- Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growthOncotarget, 2015
- Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced CachexiaJNCI: Journal of the National Cancer Institute, 2015
- Proteomic analysis of media from lung cancer cells reveals role of 14-3-3 proteins in cachexiaFrontiers in Physiology, 2015
- Circulating Carnosine Dipeptidase 1 Associates with Weight Loss and Poor Prognosis in Gastrointestinal CancerPLOS ONE, 2015
- NMR-based metabolomics reveals distinct pathways mediated by curcumin in cachexia mice bearing CT26 tumorRSC Advances, 2015
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Identification of Ubiquitin Ligases Required for Skeletal Muscle AtrophyScience, 2001